SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-292960
Filing Date
2011-11-02
Accepted
2011-11-02 17:02:34
Documents
3
Period of Report
2011-11-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d250001d8k.htm 8-K 13088
2 PRESS RELEASE d250001dex991.htm EX-99.1 13888
3 GRAPHIC g250001ex99_1pg001.jpg GRAPHIC 18659
  Complete submission text file 0001193125-11-292960.txt   53981
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51462 | Film No.: 111175162
SIC: 2836 Biological Products, (No Diagnostic Substances)